Clinical Trials Directory

Trials / Completed

CompletedNCT06408740

Physical Activity Level in Psychosis Patients

The Effect of Physical Activity Level on Social Participation, Functioning and Quality of Life in Psychosis Patients

Status
Completed
Phase
Study type
Observational
Enrollment
157 (actual)
Sponsor
Bandırma Onyedi Eylül University · Academic / Other
Sex
Female
Age
20 Years – 60 Years
Healthy volunteers
Not accepted

Summary

The aim of this study was to examine the effect of physical activity level on social participation, functioning and quality of life in patients with psychosis.

Detailed description

Positive and negative symptoms of schizophrenia will be assessed using the Positive and Negative Syndrome Scale, depression will be assessed using the Calgary Depression in Schizophrenia Scale, medication side effects will be assessed using the Glasgow Antipsychotic Side Effect Rating Scale, physical activity level will be assessed using the International Physical Activity Form, social participation will be assessed using the Social Participation Questionnaire, functioning will be assessed using the Brief Functioning Assessment Scale and quality of life will be assessed using the Nottingham Health Profile. The assessments are planned to last 30 minutes for each participant. Participants will be assessed only once and will not be reassessed.

Conditions

Timeline

Start date
2023-09-20
Primary completion
2024-03-20
Completion
2024-04-20
First posted
2024-05-10
Last updated
2024-05-10

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT06408740. Inclusion in this directory is not an endorsement.